SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-045273
Filing Date
2024-05-20
Accepted
2024-05-20 17:24:47
Documents
70
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0206522-10q_biomx.htm   iXBRL 10-Q 637803
2 FORM OF INDEMNIFICATION AGREEMENT ea020652201ex10-2_biomx.htm EX-10.2 76392
3 CERTIFICATION ea020652201ex31-1_biomx.htm EX-31.1 7941
4 CERTIFICATION ea020652201ex31-2_biomx.htm EX-31.2 7816
5 CERTIFICATION ea020652201ex32_biomx.htm EX-32 5295
  Complete submission text file 0001213900-24-045273.txt   4834144

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE phge-20240331.xsd EX-101.SCH 66632
7 XBRL CALCULATION FILE phge-20240331_cal.xml EX-101.CAL 42418
8 XBRL DEFINITION FILE phge-20240331_def.xml EX-101.DEF 276183
9 XBRL LABEL FILE phge-20240331_lab.xml EX-101.LAB 523135
10 XBRL PRESENTATION FILE phge-20240331_pre.xml EX-101.PRE 287146
74 EXTRACTED XBRL INSTANCE DOCUMENT ea0206522-10q_biomx_htm.xml XML 460600
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38762 | Film No.: 24965943
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)